Overview
The study involves MS patients with and without neuropsychological disorders.
The patient will benefit from:
- A routine neuropsychological assessment, including a cognitive and emotional assessment
- A clinical examination
- A three-dimensional analysis of movement
Eligibility
Inclusion Criteria:
- Understanding and able to speak French
- Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS <4
- No significant motor, cerebellar or somesthesia disorders of the upper limbs or visual disturbances (side to a visual EDSS <2)
- Absence of corticosteroid intake in the last four weeks
- Benefiting from health insurance coverage
- Not showing any flare-ups or worsening of the disease in the last 6 weeks
- No botulinum toxin injection for more than 4 months
Exclusion Criteria:
- People with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general ailments, perceptual or dysarthric disorders preventing verbal communication or reading,
- Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
- Refusal to participate after clear and fair information about the study.
- Adults under tutorship, curatorship or safeguard of justice
- With orthopedic treatment influencing walking
- Pregnant woman